BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 30885933)

  • 1. The Yin and Yang of
    Scott JE; O'Toole GA
    J Bacteriol; 2019 Jun; 201(11):. PubMed ID: 30885933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa Can Inhibit Growth of Streptococcal Species via Siderophore Production.
    Scott JE; Li K; Filkins LM; Zhu B; Kuchma SL; Schwartzman JD; O'Toole GA
    J Bacteriol; 2019 Apr; 201(8):. PubMed ID: 30718303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential potentiation of the virulence of the Pseudomonas aeruginosa cystic fibrosis liverpool epidemic strain by oral commensal Streptococci.
    Whiley RA; Sheikh NP; Mushtaq N; Hagi-Pavli E; Personne Y; Javaid D; Waite RD
    J Infect Dis; 2014 Mar; 209(5):769-80. PubMed ID: 24158959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.
    Waite RD; Qureshi MR; Whiley RA
    PLoS One; 2017; 12(3):e0173741. PubMed ID: 28301571
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members.
    Vandeplassche E; Sass A; Lemarcq A; Dandekar AA; Coenye T; Crabbé A
    Sci Rep; 2019 Sep; 9(1):12859. PubMed ID: 31492943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Streptococcus milleri group--an unrecognized cause of disease in cystic fibrosis: a case series and literature review.
    Parkins MD; Sibley CD; Surette MG; Rabin HR
    Pediatr Pulmonol; 2008 May; 43(5):490-7. PubMed ID: 18383109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannitol Does Not Enhance Tobramycin Killing of Pseudomonas aeruginosa in a Cystic Fibrosis Model System of Biofilm Formation.
    Price KE; Orazi G; Ruoff KL; Hebert WP; O'Toole GA; Mastoridis P
    PLoS One; 2015; 10(10):e0141192. PubMed ID: 26506004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environment and colonisation sequence are key parameters driving cooperation and competition between Pseudomonas aeruginosa cystic fibrosis strains and oral commensal streptococci.
    Whiley RA; Fleming EV; Makhija R; Waite RD
    PLoS One; 2015; 10(2):e0115513. PubMed ID: 25710466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis.
    Flynn JM; Cameron LC; Wiggen TD; Dunitz JM; Harcombe WR; Hunter RC
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
    Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
    Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Activity of Berberine with Azithromycin against Pseudomonas Aeruginosa Isolated from Patients with Cystic Fibrosis of Lung In Vitro and In Vivo.
    Li Y; Huang J; Li L; Liu L
    Cell Physiol Biochem; 2017; 42(4):1657-1669. PubMed ID: 28738346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa biofilms in cystic fibrosis.
    Høiby N; Ciofu O; Bjarnsholt T
    Future Microbiol; 2010 Nov; 5(11):1663-74. PubMed ID: 21133688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.
    Ferrara S; Rossi A; Ranucci S; De Fino I; Bragonzi A; Cigana C; Bertoni G
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33055260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A; Razavi S; Irajian G; Ardebili A; Erfani Y; Solgi S; Yaghoubi S; Rasaeian A; Yahyapour Y; Kafshgari R; Shoja S; Rajabnia R
    Infez Med; 2018 Sep; 26(3):226-236. PubMed ID: 30246765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of quorum sensing by Pseudomonas aeruginosa in microbial keratitis and cystic fibrosis.
    Willcox MDP; Zhu H; Conibear TCR; Hume EBH; Givskov M; Kjelleberg S; Rice SA
    Microbiology (Reading); 2008 Aug; 154(Pt 8):2184-2194. PubMed ID: 18667552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pseudomonas aeruginosa Antimicrobial Affects the Biogeography but Not Fitness of Staphylococcus aureus during Coculture.
    Barraza JP; Whiteley M
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785630
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa.
    Twomey KB; O'Connell OJ; McCarthy Y; Dow JM; O'Toole GA; Plant BJ; Ryan RP
    ISME J; 2012 May; 6(5):939-50. PubMed ID: 22134647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.